Quadrivalent influenza vaccine(0.5ml)

BIOLOGICAL2 trials

Sponsors

Sinovac Biotech Co., Ltd

Conditions

Seasonal Influenza

Phase 3

A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

CompletedNCT05245552

Sinovac Biotech Co., LtdSeasonal Influenza

Start: 2022-08-08End: 2023-08-04Updated: 2024-05-28

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

CompletedNCT06049927

Sinovac Biotech Co., LtdSeasonal Influenza

Start: 2023-09-16End: 2024-05-23Updated: 2025-08-14

Related Papers

Immunogenicity and safety of inactivated quadrivalent influenza vaccines in children aged 6-35 months: A multi-center, randomized, double-blind, active-controlled clinical trial.

2025-12-13